- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: bupranolol
    drug_mesh: MESH:D002046
    drugbank: DB:DB08808
  links:
    - key: decreases activity of
      source: MESH:D002046
      target: MESH:D011943
    - key: positively regulates
      source: MESH:D011943
      target: MESH:D013564
    - key: positively correlated with
      source: MESH:D013564
      target: MESH:D012084
    - key: positively correlated with
      source: MESH:D012084
      target: HP:0032263
    - key: positively correlated with
      source: MESH:D011943
      target: HP:0033533
    - key: positively correlated with
      source: MESH:D011943
      target: HP:0001649
    - key: positively correlated with
      source: HP:0032263
      target: MESH:D006973
    - key: positively correlated with
      source: HP:0001649
      target: MESH:D006973
    - key: positively correlated with
      source: HP:0033533
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D002046
      label: Drug
      name: bupranolol
    - id: MESH:D011943
      label: GeneFamily
      name: Receptors, Adrenergic, beta
    - id: MESH:D013564
      label: GrossAnatomicalStructure
      name: Sympathetic Nervous System
    - id: MESH:D012084
      label: GrossAnatomicalStructure
      name: Renin-Angiotensin System
    - id: HP:0001649
      label: PhenotypicFeature
      name: Tachycardia
    - id: HP:0033533
      label: PhenotypicFeature
      name: Increased cardiac output
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://go.drugbank.com/drugs/DB08808#mechanism-of-action https://en.wikipedia.org/wiki/Beta_blocker#%CE%B2-receptor_antagonism
- directed: true
  graph:
    disease: Glaucoma
    disease_mesh: MESH:D005901
    drug: bupranolol
    drug_mesh: MESH:D002046
    drugbank: DB:DB08808
  links:
      - key: decreases activity of
        source: MESH:D002046
        target: MESH:D011943
      - key: positively correlated with
        source: MESH:D011943
        target: HP:0007906
      - key: positively correlated with
        source: HP:0007906
        target: MESH:D005901
  multigraph: true
  nodes:
      - id: MESH:D002046
        label: Drug
        name: bupranolol
      - id: MESH:D011943
        label: GeneFamily
        name: Receptors, Adrenergic, beta
      - id: HP:0007906
        label: PhenotypicFeature
        name: Ocular Hypertension
      - id: MESH:D005901
        label: Disease
        name: Glaucoma
  reference: https://go.drugbank.com/drugs/DB08808#mechanism-of-action
- directed: true
  graph:
    disease: Onchocerciasis
    disease_mesh: MESH:D009855
    drug: ivermectin
    drug_mesh: MESH:D007559
    drugbank: DB:DB00602
  links:
    - key: increases activity of
      source: MESH:D007559
      target: InterPro:IPR015680
    - key: positively regulates
      source: InterPro:IPR015680
      target: GO:0005254
    - key: positively correlated with
      source: GO:0005254
      target: GO:0060081
    - key: in taxon
      source: GO:0060081
      target: NCBITaxon:6282
    - key: causes
      source: NCBITaxon:6282
      target: MESH:D009855
  multigraph: true
  nodes:
    - id: MESH:D007559
      label: Drug
      name: ivermectin
    - id: InterPro:IPR015680
      label: GeneFamily
      name: Glutamate-Gated Chloride Channel
    - id: GO:0005254
      label: MolecularActivity
      name: chloride channel activity
    - id: GO:0060081
      label: BiologicalProcess
      name: membrane hyperpolarization
    - id: NCBITaxon:6282
      label: OrganismTaxon
      name: Onchocerca volvulus
    - id: MESH:D009855
      label: Disease
      name: Onchocerciasis
  reference: https://en.wikipedia.org/wiki/Ivermectin#Mechanism_of_action https://go.drugbank.com/drugs/DB00602#mechanism-of-action https://en.wikipedia.org/wiki/Strongyloidiasis#Treatment
  comments: Disease is denoted Infection by Onchocerca volvulus in the original file.
- directed: true
  graph:
    disease: Strongyloidiasis
    disease_mesh: MESH:D013322
    drug: ivermectin
    drug_mesh: MESH:D007559
    drugbank: DB:DB00602
  links:
    - key: increases activity of
      source: MESH:D007559
      target: InterPro:IPR015680
    - key: positively regulates
      source: InterPro:IPR015680
      target: GO:0005254
    - key: positively correlated with
      source: GO:0005254
      target: GO:0060081
    - key: in taxon
      source: GO:0060081
      target: NCBITaxon:6248
    - key: causes
      source: NCBITaxon:6248
      target: MESH:D013322
  multigraph: true
  nodes:
    - id: MESH:D007559
      label: Drug
      name: ivermectin
    - id: InterPro:IPR015680
      label: GeneFamily
      name: Glutamate-Gated Chloride Channel
    - id: GO:0005254
      label: MolecularActivity
      name: chloride channel activity
    - id: GO:0060081
      label: BiologicalProcess
      name: membrane hyperpolarization
    - id: NCBITaxon:6248
      label: OrganismTaxon
      name: Strongyloides stercoralis
    - id: MESH:D013322
      label: Disease
      name: Strongyloidiasis
  reference: https://en.wikipedia.org/wiki/Ivermectin#Mechanism_of_action https://go.drugbank.com/drugs/DB00602#mechanism-of-action https://en.wikipedia.org/wiki/Strongyloidiasis#Treatment
  comments: Disease is denoted Infection by Strongyloides in the original file.
- directed: true
  graph:
    disease: Ulcerative colitis
    disease_mesh: MESH:D003093
    drug: balsalazide
    drug_mesh: MESH:C038637
    drugbank: DB:DB01014
  links:
    - key: produces
      source: MESH:C038637
      target: MESH:D019804
    - key: decreases activity of
      source: MESH:D019804
      target: MESH:D011451
    - key: decreases activity of
      source: MESH:D019804
      target: UniProt:O15111
    - key: decreases activity of
      source: MESH:D019804
      target: UniProt:O14920
    - key: positively regulates
      source: UniProt:O14920
      target: GO:0007249
    - key: positively regulates
      source: UniProt:O15111
      target: GO:0007249
    - key: positively correlated with
      source: GO:0007249
      target: MESH:D007249
    - key: decreases activity of
      source: MESH:D019804
      target: UniProt:P09917
    - key: increases activity of
      source: MESH:D019804
      target: UniProt:P37231
    - key: negatively correlated with
      source: UniProt:P37231
      target: REACT:R-HSA-1169091
    - key: positively correlated with
      source: REACT:R-HSA-1169091
      target: MESH:D007249
    - key: positively regulates
      source: UniProt:P37231
      target: GO:0060249
    - key: located in
      source: GO:0060249
      target: UBERON:0001155
    - key: participates in
      source: UniProt:P09917
      target: REACT:R-HSA-2142691
    - key: participates in
      source: MESH:D011451
      target: REACT:R-HSA-2162123
    - key: positively correlated with
      source: REACT:R-HSA-2162123
      target: MESH:D007249
    - key: positively correlated with
      source: REACT:R-HSA-2142691
      target: MESH:D007249
    - key: located in
      source: MESH:D007249
      target: UBERON:0001052
    - key: located in
      source: MESH:D007249
      target: UBERON:0001155
    - key: location of
      source: UBERON:0001052
      target: MESH:D003093
    - key: location of
      source: UBERON:0001155
      target: MESH:D003093
  multigraph: true
  nodes:
    - id: MESH:C038637
      label: Drug
      name: balsalazide
    - id: MESH:D019804
      label: Drug
      name: Mesalamine
    - id: MESH:D011451
      label: GeneFamily
      name: Prostaglandin-Endoperoxide Synthases
    - id: UniProt:P09917
      label: Protein
      name: Polyunsaturated fatty acid 5-lipoxygenase
    - id: UniProt:P37231
      label: Protein
      name: Peroxisome proliferator-activated receptor gamma
    - id: UniProt:O15111
      label: Protein
      name: Inhibitor of nuclear factor kappa-B kinase subunit alpha
    - id: UniProt:O14920
      label: Protein
      name: Inhibitor of nuclear factor kappa-B kinase subunit beta
    - id: GO:0007249
      label: BiologicalProcess
      name: I-kappaB kinase/NF-kappaB signaling
    - id: GO:0060249
      label: BiologicalProcess
      name: anatomical structure homeostasis
    - id: REACT:R-HSA-2142691
      label: Pathway
      name: Synthesis of Leukotrienes (LT) and Eoxins (EX)
    - id: REACT:R-HSA-2162123
      label: Pathway
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: REACT:R-HSA-1169091
      label: Pathway
      name: Activation of NF-kappaB in B cells
    - id: MESH:D007249
      label: BiologicalProcess
      name: Inflammation
    - id: UBERON:0001052
      label: GrossAnatomicalStructure
      name: rectum
    - id: UBERON:0001155
      label: GrossAnatomicalStructure
      name: colon
    - id: MESH:D003093
      label: Disease
      name: Ulcerative colitis
  reference: https://go.drugbank.com/drugs/DB01014#mechanism-of-action https://go.drugbank.com/drugs/DB00244#mechanism-of-action https://pubmed.ncbi.nlm.nih.gov/20151072/ https://go.drugbank.com/drugs/DB00244#BE0004655 https://en.wikipedia.org/wiki/CHUK#Clinical_significance https://en.wikipedia.org/wiki/IKK2#Clinical_significance
  comments: Balsalazide is a prodrug and it releases mesalazine in the large intestine, the active site of ulcerative colitis (https://en.wikipedia.org/wiki/Balsalazide https://en.wikipedia.org/wiki/Mesalazine#Chemistry).
- directed: true
  graph:
      disease: Schizophrenia
      disease_mesh: MESH:D012559
      drug: quetiapine
      drug_mesh: MESH:D000069348
      drugbank: DB:DB01224
  links:
    -   key: decreases activity of
        source: MESH:D000069348
        target: UniProt:P14416
    -   key: decreases activity of
        source: MESH:D000069348
        target: UniProt:P28223
    -   key: positively regulates
        source: UniProt:P28223
        target: GO:0014046
    -   key: positively regulates
        source: UniProt:P14416
        target: GO:0014046
    -   key: increases abundance of
        source: GO:0014046
        target: CHEBI:18243
    -   key: located in
        source: CHEBI:18243
        target: UBERON:0001910
    -   key: correlated with
        source: UBERON:0001910
        target: HP:0000709
    -   key: positively correlated with
        source: HP:0000709
        target: MESH:D012559
    -   key: located in
        source: CHEBI:18243
        target: UBERON:0009834
    -   key: correlated with
        source: UBERON:0009834
        target: HP:0100543
    -   key: correlated with
        source: UBERON:0009834
        target: HP:0030213
    -   key: correlated with
        source: UBERON:0009834
        target: HP:0012154
    -   key: correlated with
        source: UBERON:0009834
        target: HP:0002465
    -   key: correlated with
        source: UBERON:0009834
        target: HP:0000741
    -   key: positively correlated with
        source: HP:0100543
        target: MESH:D012559
    -   key: positively correlated with
        source: HP:0030213
        target: MESH:D012559
    -   key: positively correlated with
        source: HP:0012154
        target: MESH:D012559
    -   key: positively correlated with
        source: HP:0002465
        target: MESH:D012559
    -   key: positively correlated with
        source: HP:0000741
        target: MESH:D012559
  multigraph: true
  nodes:
    -   id: MESH:D000069348
        label: Drug
        name: quetiapine
    -   id: UniProt:P28223
        label: Protein
        name: 5-hydroxytryptamine receptor 2A
    -   id: UniProt:P14416
        label: Protein
        name: D(2) dopamine receptor
    -   id: GO:0014046
        label: BiologicalProcess
        name: dopamine secretion
    -   id: CHEBI:18243
        label: ChemicalSubstance
        name: dopamine
    -   id: UBERON:0009834
        label: GrossAnatomicalStructure
        name: dorsolateral prefrontal cortex
    -   id: UBERON:0001910
        label: GrossAnatomicalStructure
        name: medial forebrain bundle
    -   id: HP:0100543
        label: PhenotypicFeature
        name: Cognitive impairment
    -   id: HP:0030213
        label: PhenotypicFeature
        name: Emotional blunting
    -   id: HP:0012154
        label: PhenotypicFeature
        name: Anhedonia
    -   id: HP:0002465
        label: PhenotypicFeature
        name: Poor speech
    -   id: HP:0000741
        label: PhenotypicFeature
        name: Apathy
    -   id: HP:0000709
        label: PhenotypicFeature
        name: Psychosis
    -   id: MESH:D012559
        label: Disease
        name: Schizophrenia
  reference: https://go.drugbank.com/drugs/DB01224#mechanism-of-action https://go.drugbank.com/drugs/DB01224#BE0000451 https://go.drugbank.com/drugs/DB01224#BE0000756
- directed: true
  graph:
    disease: Chronic phase chronic myeloid leukemia
    disease_mesh: MESH:D015466
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
    - key: decreases activity of
      source: MESH:D000068877
      target: MESH:D016044
    - key: positively regulates
      source: MESH:D016044
      target: GO:0004674
    - key: positively correlated with
      source: GO:0004674
      target: GO:0007266
    - key: positively correlated with
      source: GO:0007266
      target: GO:0008283
    - key: negatively correlated with
      source: GO:0007266
      target: GO:0006915
    - key: positively correlated with
      source: GO:0008283
      target: MESH:D015466
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D015466
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: MESH:D016044
      label: Protein
      name: Fusion Proteins, bcr-abl
    - id: GO:0004674
      label: MolecularActivity
      name: protein serine/threonine kinase activity
    - id: GO:0007266
      label: BiologicalProcess
      name: Rho protein signal transduction
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: MESH:D015466
      label: Disease
      name: Chronic phase chronic myeloid leukemia
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://go.drugbank.com/drugs/DB00619#mechanism-of-action https://en.wikipedia.org/wiki/Imatinib#Chronic_myelogenous_leukemia
  comments: Imatinib also modulates other protein targets and is an indication for other malignancies (https://en.wikipedia.org/wiki/Imatinib#Medical_uses).
- directed: true
  graph:
    disease: Blast Crisis
    disease_mesh: MESH:D001752
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
    - key: decreases activity of
      source: MESH:D000068877
      target: MESH:D016044
    - key: positively correlated with
      source: MESH:D016044
      target: GO:0007266
    - key: positively correlated with
      source: GO:0007266
      target: GO:0008283
    - key: positively correlated with
      source: GO:0008283
      target: HP:0001974
    - key: manifestation of
      source: HP:0001974
      target: MESH:D001752
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: MESH:D016044
      label: Protein
      name: Fusion Proteins, bcr-abl
    - id: GO:0007266
      label: BiologicalProcess
      name: Rho protein signal transduction
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: HP:0001974
      label: PhenotypicFeature
      name: Leukocytosis
    - id: MESH:D001752
      label: Disease
      name: Blast Crisis
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://en.wikipedia.org/wiki/Leukocytosis#Causes https://en.wikipedia.org/wiki/Chronic_myelogenous_leukemia#Chronic_phase_2
  comments: The disease is denoted Blastic phase chronic myeloid leukemia in the original file.
- directed: true
  graph:
    disease: Pdgfra-Associated Chronic Eosinophilic Leukemia
    disease_mesh: MESH:C580364
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
    - key: decreases activity of
      source: MESH:D000068877
      target: MESH:D017479
    - key: positively regulates
      source: MESH:D017479
      target: GO:0048008
    - key: positively correlated with
      source: GO:0048008
      target: GO:0008283
    - key: positively correlated with
      source: GO:0008283
      target: HP:0001880
    - key: manifestation of
      source: HP:0001880
      target: MESH:C580364
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: MESH:D017479
      label: GeneFamily
      name: Receptors, Platelet-Derived Growth Factor
    - id: GO:0048008
      label: BiologicalProcess
      name: platelet-derived growth factor receptor signaling pathway
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: HP:0001880
      label: PhenotypicFeature
      name: Eosinophilia
    - id: MESH:C580364
      label: Disease
      name: Pdgfra-Associated Chronic Eosinophilic Leukemia
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://go.drugbank.com/drugs/DB00619#BE0000205 https://go.drugbank.com/drugs/DB00619#BE0000852 https://en.wikipedia.org/wiki/Chronic_eosinophilic_leukemia https://en.wikipedia.org/wiki/Eosinophilia#Chronic_eosinophilic_leukemia_(NOS) https://en.wikipedia.org/wiki/Imatinib#Other
  comments: The disease is denoted Chronic eosinophilic leukemia in the original file. The malignancy is driven by FIP1L1-PDGFRA fusion genes (https://en.wikipedia.org/wiki/FIP1L1#FIP1L1-PDGFRA_fusion_genes).
- directed: true
  graph:
    disease: Hypereosinophilic Syndrome
    disease_mesh: MESH:D017681
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
    - key: decreases activity of
      source: MESH:D000068877
      target: MESH:D015514
    - key: derives from
      source: MESH:D015514
      target: UniProt:P16234
    - key: positively regulates
      source: UniProt:P16234
      target: GO:0008283
    - key: positively correlated with
      source: GO:0008283
      target: HP:0001880
    - key: manifestation of
      source: HP:0001880
      target: MESH:D017681
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: MESH:D015514
      label: GeneFamily
      name: Oncogene Proteins, Fusion
    - id: UniProt:P16234
      label: Protein
      name: Platelet-derived growth factor receptor alpha
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: HP:0001880
      label: PhenotypicFeature
      name: Eosinophilia
    - id: MESH:D017681
      label: Disease
      name: Hypereosinophilic Syndrome
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://go.drugbank.com/drugs/DB00619#BE0000205 https://go.drugbank.com/drugs/DB00619#BE0000852 https://en.wikipedia.org/wiki/Imatinib#Other
  comments: The disease is denoted Idiopathic hypereosinophilic syndrome in the original file. Treatment with imatinib is indicated for patients who have a tyrosine kinase fusion protein (https://en.wikipedia.org/wiki/Hypereosinophilic_syndrome#Diagnosis), a PDGFRA-FIP1L1 chimera, where PDGR is an oncogene (https://en.wikipedia.org/wiki/Oncogene#Classification).
- directed: true
  graph:
    disease: Gastrointestinal stromal tumor
    disease_mesh: MESH:D046152
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
    - key: decreases activity of
      source: MESH:D000068877
      target: UniProt:P10721
    - key: decreases activity of
      source: MESH:D000068877
      target: UniProt:P16234
    - key: positively regulates
      source: UniProt:P16234
      target: GO:0035790
    - key: positively correlated with
      source: GO:0035790
      target: GO:0008283
    - key: positively correlated with
      source: GO:0035790
      target: MESH:D002470
    - key: positively regulates
      source: UniProt:P10721
      target: GO:0038109
    - key: positively correlated with
      source: GO:0038109
      target: GO:0008283
    - key: positively correlated with
      source: GO:0038109
      target: MESH:D002470
    - key: positively correlated with
      source: GO:0038109
      target: GO:0030154
    - key: positively correlated with
      source: GO:0008283
      target: MESH:D046152
    - key: positively correlated with
      source: MESH:D002470
      target: MESH:D046152
    - key: positively correlated with
      source: GO:0030154
      target: MESH:D046152
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: UniProt:P10721
      label: Protein
      name: Mast/stem cell growth factor receptor Kit
    - id: UniProt:P16234
      label: Protein
      name: Platelet-derived growth factor receptor alpha
    - id: GO:0035790
      label: BiologicalProcess
      name: platelet-derived growth factor receptor-alpha signaling pathway
    - id: GO:0038109
      label: BiologicalProcess
      name: Kit signaling pathway
    - id: GO:0030154
      label: BiologicalProcess
      name: cell differentiation
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: MESH:D002470
      label: BiologicalProcess
      name: Cell Survival
    - id: MESH:D046152
      label: Disease
      name: Gastrointestinal stromal tumor
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://en.wikipedia.org/wiki/Imatinib#Gastrointestinal_stromal_tumors https://go.drugbank.com/drugs/DB00619#BE0000453 https://go.drugbank.com/drugs/DB00619#BE0000852
  comments: The majority of Gastrointestinal stromal tumor patients have mutations on the KIT or PDGFRA genes (95% of all patients).
- directed: true
  graph:
    disease: Dermatofibrosarcoma
    disease_mesh: MESH:D018223
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
    - key: decreases activity of
      source: MESH:D000068877
      target: MESH:D050506
    - key: derives from
      source: MESH:D050506
      target: MESH:D010982
    - key: positively regulates
      source: MESH:D010982
      target: GO:0030154
    - key: positively regulates
      source: MESH:D010982
      target: GO:0008283
    - key: positively regulates
      source: MESH:D010982
      target: MESH:D002470
    - key: positively correlated with
      source: GO:0008283
      target: MESH:D018223
    - key: positively correlated with
      source: MESH:D002470
      target: MESH:D018223
    - key: positively correlated with
      source: GO:0030154
      target: MESH:D018223
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: MESH:D050506
      label: GeneFamily
      name: Mutant Chimeric Proteins
    - id: MESH:D010982
      label: GeneFamily
      name: Platelet-Derived Growth Factor
    - id: GO:0030154
      label: BiologicalProcess
      name: cell differentiation
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: MESH:D002470
      label: BiologicalProcess
      name: Cell Survival
    - id: MESH:D018223
      label: Disease
      name: Dermatofibrosarcoma
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://en.wikipedia.org/wiki/Dermatofibrosarcoma_protuberans#Pathophysiology https://en.wikipedia.org/wiki/Imatinib#Dermatofibrosarcoma_protuberans_(DFSP)
  comments: The majority of Dermatofibrosarcoma tumours have two genes fused due to a translocation involving the collagen gene (COL1A1) and platelet-derived growth factor (PDGF) genes.
- directed: true
  graph:
    disease: Mastocytosis, Systemic
    disease_mesh: MESH:D034721
    drug: imatinib
    drug_mesh: MESH:D000068877
    drugbank: DB:DB00619
  links:
      - key: decreases activity of
        source: MESH:D000068877
        target: UniProt:P10721
      - key: positively regulates
        source: UniProt:P10721
        target: GO:0038109
      - key: positively correlated with
        source: GO:0038109
        target: GO:0008283
      - key: positively correlated with
        source: GO:0038109
        target: MESH:D002470
      - key: positively correlated with
        source: GO:0038109
        target: GO:0030154
      - key: increases abundance of
        source: GO:0008283
        target: MESH:D008407
      - key: correlated with
        source: MESH:D008407
        target: MESH:D034721
      - key: positively correlated with
        source: MESH:D002470
        target: MESH:D034721
      - key: positively correlated with
        source: GO:0030154
        target: MESH:D034721
  multigraph: true
  nodes:
    - id: MESH:D000068877
      label: Drug
      name: imatinib
    - id: UniProt:P10721
      label: Protein
      name: Mast/stem cell growth factor receptor Kit
    - id: GO:0038109
      label: BiologicalProcess
      name: Kit signaling pathway
    - id: GO:0030154
      label: BiologicalProcess
      name: cell differentiation
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: MESH:D002470
      label: BiologicalProcess
      name: Cell Survival
    - id: MESH:D008407
      label: Cell
      name: Mast Cells
    - id: MESH:D034721
      label: Disease
      name: Mastocytosis, Systemic
  reference: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate https://go.drugbank.com/drugs/DB00619#BE0000453
  comments: The disease is denoted Systemic mast cell disease in the original file.
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: MESH:D020746
    - key: positively regulates
      source: MESH:D020746
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0033533
    - key: positively correlated with
      source: HP:0033533
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: MESH:D020746
      label: GeneFamily
      name: Calcium Channels, L-Type
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033533
      label: PhenotypicFeature
      name: Increased cardiac output
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://go.drugbank.com/drugs/DB00661#mechanism-of-action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/ https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
- directed: true
  graph:
    disease: Atrial fibrillation
    disease_mesh: MESH:D001281
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: MESH:D020746
    - key: positively regulates
      source: MESH:D020746
      target: GO:0061337
    - key: positively correlated with
      source: GO:0061337
      target: MESH:D006339
    - key: positively correlated with
      source: MESH:D006339
      target: HP:0001692
    - key: manifestation of
      source: HP:0001692
      target: MESH:D001281
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: MESH:D020746
      label: GeneFamily
      name: Calcium Channels, L-Type
    - id: GO:0061337
      label: BiologicalProcess
      name: cardiac conduction
    - id: MESH:D006339
      label: BiologicalProcess
      name: Heart Rate
    - id: HP:0001692
      label: PhenotypicFeature
      name: Atrial arrhythmia
    - id: MESH:D001281
      label: Disease
      name: Atrial fibrillation
  reference: https://go.drugbank.com/drugs/DB00661#mechanism-of-action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/ https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents https://en.wikipedia.org/wiki/Atrial_fibrillation#Rate_control
- directed: true
  graph:
    disease: Acute coronary syndrome
    disease_mesh: MESH:D054058
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: MESH:D020746
    - key: positively regulates
      source: MESH:D020746
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: MESH:D017202
    - key: positively correlated with
      source: MESH:D017202
      target: MESH:D054058
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: MESH:D020746
      label: GeneFamily
      name: Calcium Channels, L-Type
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: MESH:D017202
      label: PhenotypicFeature
      name: Myocardial Ischemia
    - id: MESH:D054058
      label: Disease
      name: Acute coronary syndrome
  reference: https://go.drugbank.com/drugs/DB00661#mechanism-of-action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/ https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents
- directed: true
  graph:
    disease: Angina pectoris
    disease_mesh: MESH:D000787
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: MESH:D020746
    - key: positively regulates
      source: MESH:D020746
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: MESH:D017202
    - key: positively correlated with
      source: MESH:D017202
      target: MESH:D000787
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: MESH:D020746
      label: GeneFamily
      name: Calcium Channels, L-Type
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: MESH:D017202
      label: PhenotypicFeature
      name: Myocardial Ischemia
    - id: MESH:D000787
      label: Disease
      name: Angina pectoris
  reference: https://go.drugbank.com/drugs/DB00661#mechanism-of-action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/ https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents https://en.wikipedia.org/wiki/Angina#Treatment
- directed: true
  graph:
    disease: Angina Pectoris, Variant
    disease_mesh: MESH:D000788
    drug: verapamil
    drug_mesh: MESH:D014700
    drugbank: DB:DB00661
  links:
    - key: decreases activity of
      source: MESH:D014700
      target: MESH:D020746
    - key: positively regulates
      source: MESH:D020746
      target: GO:0060402
    - key: positively correlated with
      source: GO:0060402
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: MESH:D017202
    - key: positively correlated with
      source: MESH:D017202
      target: MESH:D000788
  multigraph: true
  nodes:
    - id: MESH:D014700
      label: Drug
      name: verapamil
    - id: MESH:D020746
      label: GeneFamily
      name: Calcium Channels, L-Type
    - id: GO:0060402
      label: BiologicalProcess
      name: calcium ion transport into cytosol
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: MESH:D017202
      label: PhenotypicFeature
      name: Myocardial Ischemia
    - id: MESH:D000788
      label: Disease
      name: Angina Pectoris, Variant
  reference: https://go.drugbank.com/drugs/DB00661#mechanism-of-action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/ https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents https://en.wikipedia.org/wiki/Variant_angina#Maintenance
  comments: The disease is denoted as Prinzmetal angina in the original file.
- directed: true
  graph:
    disease: Major depressive disorder
    disease_mesh: MESH:D003865
    drug: dosulepin
    drug_mesh: MESH:D004308
    drugbank: DB:DB09167
  links:
    - key: negatively regulates
      source: MESH:D004308
      target: UniProt:P31645
    - key: negatively regulates
      source: MESH:D004308
      target: UniProt:P23975
    - key: positively regulates
      source: UniProt:P31645
      target: GO:0051610
    - key: positively regulates
      source: UniProt:P23975
      target: GO:0051620
    - key: positively correlated with
      source: GO:0051620
      target: HP:0000716
    - key: positively correlated with
      source: GO:0051610
      target: HP:0000716
    - key: manifestation of
      source: HP:0000716
      target: MESH:D003865
  multigraph: true
  nodes:
    - id: MESH:D004308
      label: Drug
      name: dosulepin
    - id: UniProt:P31645
      label: Protein
      name: Sodium-dependent serotonin transporter
    - id: UniProt:P23975
      label: Protein
      name: Sodium-dependent noradrenaline transporter
    - id: GO:0051610
      label: BiologicalProcess
      name: serotonin uptake
    - id: GO:0051620
      label: BiologicalProcess
      name: norepinephrine uptake
    - id: HP:0000716
      label: PhenotypicFeature
      name: Depressivity
    - id: MESH:D003865
      label: Disease
      name: Major depressive disorder
  reference: https://go.drugbank.com/drugs/DB09167#BE0000486 https://go.drugbank.com/drugs/DB09167#BE0000749 https://en.wikipedia.org/wiki/Dosulepin#Pharmacodynamics https://pubmed.ncbi.nlm.nih.gov/2670509/
- directed: true
  graph:
      disease: Bipolar Disorder
      disease_mesh: MESH:D001714
      drug: quetiapine
      drug_mesh: MESH:D000069348
      drugbank: DB:DB01224
  links:
    -   key: decreases activity of
        source: MESH:D000069348
        target: UniProt:P23975
    -   key: positively regulates
        source: UniProt:P23975
        target: GO:0051620
    -   key: positively correlated with
        source: GO:0051620
        target: HP:0000716
    -   key: positively correlated with
        source: GO:0051620
        target: HP:0100754
    -   key: manifestation of
        source: HP:0000716
        target: MESH:D001714
    -   key: manifestation of
        source: HP:0100754
        target: MESH:D001714
  multigraph: true
  nodes:
    -   id: MESH:D000069348
        label: Drug
        name: quetiapine
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051620
        label: BiologicalProcess
        name: norepinephrine uptake
    -   id: HP:0000716
        label: PhenotypicFeature
        name: Depressivity
    -   id: HP:0100754
        label: PhenotypicFeature
        name: Mania
    -   id: MESH:D001714
        label: Disease
        name: Bipolar Disorder
  reference: https://go.drugbank.com/drugs/DB01224#mechanism-of-action https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC6A2#drugs_compounds https://en.wikipedia.org/wiki/Quetiapine#cite_note-pmid18059438-50 https://pubmed.ncbi.nlm.nih.gov/20307622/ https://pubmed.ncbi.nlm.nih.gov/20931407/
  comments: The disease is denoted as Bipolar affective disorder, current episode depression in the original file. It seems that either Quetiapine or its metabolite (Norquetiapine, also known as N-desalkylquetiapine) could bind to UniProt:P23975 and inhibit its function and is associated with lower synaptic norepinephrine levels (https://en.wikipedia.org/wiki/Quetiapine#Pharmacokinetics https://www.ebi.ac.uk/chembl/document_report_card/CHEMBL3526075/).

